Photo by frankieleon via Flickr.
BY LINDA A. JOHNSON
AP MEDICAL WRITER
TRENTON, N.J. (AP) — A panel of Food and Drug Administration advisers voted against approving a new opioid painkiller with a unique feature for deterring abuse: It releases a deep-blue dye if someone tries to get high by crushing, chewing or snorting pills.
Panelists voted overwhelmingly against approving Intellipharmaceutics International’s generic version of extended-release Oxycontin, a key drug in the U.S. opioid addiction epidemic. The FDA usually follows its advisers’ advice.
Doctors and scientists raised many concerns about the dye’s safety for intended patients, and its effectiveness in deterring opioid abusers. Most said the company hadn’t done enough studies of the drug.
Some suggested blue stains around the mouth or nose from trying to abuse the drug could become popular among addicts. Others said the dye’s “Scarlet Letter” shaming approach was insensitive.
You can keep up with all of HIGH TIMES’ news right here.
Who Invented The Weed Brownie?
Canadian Police Apologize For Telling Kids ‘Doobies Make Boobies’
Illegal Immigrant Found In Walls Of UK Marijuana Grow
The Car That Tupac Shakur Died In Is Being Sold For $1.5 Million
Products1 week ago
10 Best Portable Vaporizers of 2017
Culture4 days ago
14 High Profile People Who Like To Get High
Products7 days ago
10 Best Quartz Bangers Of 2017
Culture6 days ago
The Origins of Your Favorite Weed Slang
Entertainment1 week ago
Nine Authors Who Smoked Weed
Culture3 days ago
8 of The Craziest Weed Conspiracies That Might Be True
Culture5 days ago
7 Scientists Who Smoked Weed
Entertainment7 days ago
Netflix’s Weed-Themed Sitcom ‘Disjointed’ Canceled